海圣医疗
(920166)
| 流通市值：4.63亿 | | | 总市值：14.67亿 |
| 流通股本：2376.47万 | | | 总股本：7529.41万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 162,345,228.59 | 73,495,192.83 | 345,286,102.13 | 247,713,864.91 |
| 营业收入 | 162,345,228.59 | 73,495,192.83 | 345,286,102.13 | 247,713,864.91 |
| 二、营业总成本 | 128,373,015.8 | 59,956,210.72 | 254,337,555.78 | 183,344,742.23 |
| 营业成本 | 81,873,627.02 | 37,636,300.91 | 165,709,869.47 | 119,785,337.66 |
| 税金及附加 | 1,944,961.41 | 916,899.16 | 4,155,950.72 | 3,060,112.85 |
| 销售费用 | 15,980,722.59 | 7,607,014.51 | 35,804,461.02 | 26,181,834.22 |
| 管理费用 | 19,513,849.78 | 8,691,363.5 | 28,976,394.58 | 21,255,762.49 |
| 研发费用 | 10,128,264.78 | 4,657,122.49 | 19,498,105.93 | 13,047,517.85 |
| 财务费用 | -1,068,409.78 | 447,510.15 | 192,774.06 | 14,177.16 |
| 其中:利息费用 | 5,128.61 | 615.54 | 11,571.43 | 10,038 |
| 其中:利息收入 | 2,146,721.11 | 81,583.12 | 302,943.79 | 232,327.22 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,999.01 | - | - | - |
| 加:投资收益 | 152,264.38 | 41,798.63 | 38,613.82 | 65.87 |
| 资产处置收益 | 19,016.1 | - | - | - |
| 资产减值损失(新) | -109,556.91 | -112,641.47 | -96,927.99 | -153,156.29 |
| 信用减值损失(新) | 744,460.49 | 1,154,803.67 | -562,922.98 | -60,989.12 |
| 其他收益 | 1,317,547.73 | 318,029.07 | 7,591,785.73 | 3,151,501.98 |
| 四、营业利润 | 36,099,943.59 | 14,940,972.01 | 97,919,094.93 | 67,306,545.12 |
| 加:营业外收入 | - | 1.15 | 280,920.75 | 25,681.55 |
| 减:营业外支出 | 195,241.12 | 190,166.32 | 455,556.95 | 455,375.81 |
| 五、利润总额 | 35,904,702.47 | 14,750,806.84 | 97,744,458.73 | 66,876,850.86 |
| 减:所得税费用 | 5,242,292.79 | 2,648,933.19 | 11,928,567.6 | 8,094,836.98 |
| 六、净利润 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| 扣除非经常损益后的净利润 | 30,003,276.07 | 12,252,685.16 | 80,393,732.37 | 56,845,030.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.43 | 0.18 | 1.34 | 0.92 |
| (二)稀释每股收益 | 0.43 | 0.18 | 1.34 | 0.92 |
| 九、综合收益总额 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| 归属于母公司股东的综合收益总额 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| 公告日期 | 2026-08-24 | 2026-04-28 | 2026-01-22 | 2025-11-03 |
| 审计意见(境内) | | | 标准无保留意见 | |